Chemoproteomics in covalent cancer drug discovery.
Covalent small-molecule drugs have re-emerged as an important class of targeted therapeutics because they can sustain target engagement and exploit nucleophilic residues inaccessible to reversible ligands. However, covalent pharmacology has historically been constrained by concerns about nonspecific reactivity and limi...